Mark Collinge

2.3k total citations
37 papers, 1.8k citations indexed

About

Mark Collinge is a scholar working on Immunology, Molecular Biology and Small Animals. According to data from OpenAlex, Mark Collinge has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Small Animals. Recurrent topics in Mark Collinge's work include Immunotoxicology and immune responses (9 papers), Animal testing and alternatives (9 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Mark Collinge is often cited by papers focused on Immunotoxicology and immune responses (9 papers), Animal testing and alternatives (9 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Mark Collinge collaborates with scholars based in United States, Italy and France. Mark Collinge's co-authors include Jeffrey R. Bender, William C. Sessa, M. Page Haynes, Ruggero Pardi, Kerry S. Russell, David Fulton, Manuel Morales‐Ruiz, Mehran M. Sadeghi, Roland Baron and Koji Hisamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Mark Collinge

35 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Collinge United States	20	749	419	401	295	271	37	1.8k
Michał Bieńkowski Poland	24	1.2k 1.6×	271 0.6×	260 0.6×	293 1.0×	322 1.2×	80	2.3k
Weiping Yuan China	30	2.1k 2.8×	487 1.2×	405 1.0×	143 0.5×	304 1.1×	141	3.3k
Dong‐bao Chen United States	27	759 1.0×	424 1.0×	305 0.8×	134 0.5×	79 0.3×	74	2.1k
Elisa Petrangeli Italy	27	625 0.8×	263 0.6×	327 0.8×	477 1.6×	277 1.0×	59	1.8k
Akiko Kimura Japan	26	1.4k 1.9×	357 0.9×	252 0.6×	139 0.5×	545 2.0×	49	2.4k
Reid Huber United States	19	1.5k 2.0×	537 1.3×	511 1.3×	453 1.5×	570 2.1×	50	3.5k
Gang Ning United States	21	748 1.0×	257 0.6×	190 0.5×	166 0.6×	98 0.4×	54	2.2k
Anja Steffen Germany	21	1.3k 1.7×	297 0.7×	412 1.0×	365 1.2×	496 1.8×	34	2.4k
Hyo Kyun Chung South Korea	28	986 1.3×	513 1.2×	128 0.3×	401 1.4×	440 1.6×	44	2.2k
James D. Dunbar United States	21	2.5k 3.3×	316 0.8×	261 0.7×	148 0.5×	250 0.9×	23	3.1k

Countries citing papers authored by Mark Collinge

Since Specialization

Citations

This map shows the geographic impact of Mark Collinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Collinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Collinge more than expected).

Fields of papers citing papers by Mark Collinge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Collinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Collinge. The network helps show where Mark Collinge may publish in the future.

Co-authorship network of co-authors of Mark Collinge

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Collinge. A scholar is included among the top collaborators of Mark Collinge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Collinge. Mark Collinge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Collinge, Mark, Haley D. Neff‐LaFord, Birgit Fogal, et al.. (2024). Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey. Regulatory Toxicology and Pharmacology. 150. 105630–105630. 1 indexed citations

Tanaka, Yoshiya, Tsutomu Takeuchi, Hernán Valdez, et al.. (2024). Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib. Modern Rheumatology. 34(6). 1115–1124.

Collinge, Mark, Patricia Schneider, Dingzhou Li, et al.. (2020). Cross-company evaluation of the human lymphocyte activation assay. Journal of Immunotoxicology. 17(1). 51–58. 4 indexed citations

Collinge, Mark, et al.. (2018). Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats – Comparison of juvenile and adult responses. Regulatory Toxicology and Pharmacology. 94. 306–322. 8 indexed citations

Rao, Gautham K., Albert Wong, Mark Collinge, et al.. (2018). T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and K. PLoS ONE. 13(7). e0201103–e0201103. 1 indexed citations

Weinhold, Kent J., Jack F. Bukowski, Todd V. Brennan, et al.. (2018). Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers. Clinical Immunology. 191. 10–20. 26 indexed citations

Lebrec, Hervé, Darrell R. Boverhof, Mark Collinge, et al.. (2014). The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation. Regulatory Toxicology and Pharmacology. 69(1). 7–21. 31 indexed citations

Thorn, Mitchell, et al.. (2014). Evaluation of a novel delayed-type hypersensitivity assay toCandida albicansin adult and neonatal rats. Journal of Immunotoxicology. 12(4). 350–360. 4 indexed citations

Collinge, Mark, et al.. (2013). Validation of aCandida albicansdelayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments. Journal of Immunotoxicology. 10(4). 341–348. 2 indexed citations

10.

Collinge, Mark, Leigh Ann Burns‐Naas, Gary J. Chellman, et al.. (2012). Developmental immunotoxicity (DIT) testing of pharmaceuticals: Current practices, state of the science, knowledge gaps, and recommendations. Journal of Immunotoxicology. 9(2). 210–230. 19 indexed citations

11.

Zhang, Jiange, Yasha S. Modi, Timur O. Yarovinsky, et al.. (2012). Macrophage β2 Integrin–Mediated, HuR-Dependent Stabilization of Angiogenic Factor–Encoding mRNAs in Inflammatory Angiogenesis. American Journal Of Pathology. 180(4). 1751–1760. 48 indexed citations

12.

Collinge, Mark, Vinod S. Ramgolam, Oran Ayalon, et al.. (2006). LFA-1-Dependent HuR Nuclear Export and Cytokine mRNA Stabilization in T Cell Activation. The Journal of Immunology. 176(4). 2105–2113. 76 indexed citations

13.

Haynes, M. Page, Lei Li, Kerry S. Russell, et al.. (2003). Src Kinase Mediates Phosphatidylinositol 3-Kinase/Akt-dependent Rapid Endothelial Nitric-oxide Synthase Activation by Estrogen. Journal of Biological Chemistry. 278(4). 2118–2123. 264 indexed citations

14.

Rossetti, Grazisa, et al.. (2002). Integrin‐dependent regulation of gene expression in leukocytes. Immunological Reviews. 186(1). 189–207. 27 indexed citations

15.

NIEMEYER, CARTER C., et al.. (2001). Gray Wolf Restoration in the Northwestern United States. Insecta mundi. 10 indexed citations

16.

Sadeghi, Mehran M., Mark Collinge, Ruggero Pardi, & Jeffrey R. Bender. (2000). Simvastatin Modulates Cytokine-Mediated Endothelial Cell Adhesion Molecule Induction: Involvement of an Inhibitory G Protein. The Journal of Immunology. 165(5). 2712–2718. 117 indexed citations

17.

Collinge, Mark, Ruggero Pardi, & Jeffrey R. Bender. (1998). Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion.. PubMed. 161(4). 1589–93. 33 indexed citations

18.

Watterson, D. Martin, Mark Collinge, Thomas J. Lukas, et al.. (1995). Multiple gene products are produced from a novel protein kinase transcription region. FEBS Letters. 373(3). 217–220. 48 indexed citations

19.

Lukas, Thomas J., Mark Collinge, Jacques Haiech, & D. Martin Watterson. (1994). Gain of function mutations for yeast calmodulin and calcium dependent regulation of protein kinase activity. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1223(3). 341–347. 2 indexed citations

20.

Collinge, Mark, Warren E. Zimmer, R L Shattuck, et al.. (1992). Structure and Expression of a Calcium-Binding Protein Gene Contained within a Calmodulin-Regulated Protein Kinase Gene. Molecular and Cellular Biology. 12(5). 2359–2371. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact